Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions often highlight the significance of the trial, with comments referencing its novelty and potential to influence aging treatments. The tone varies from enthusiastic to cautious, with phrases like 'positive results' and 'potential benefits' underscoring a focus on medical advancements and their implications for elderly care.
Most discussions recognize the positive results of the trial, supporting the potential benefits of young plasma infusions in older patients.
Participants show high interest, often referencing the clinical trial and its results, indicating curiosity about medical advances and aging.
Posts mention specific studies, methods, and implications, reflecting moderate but thoughtful engagement with the research.
The trial is viewed as potentially impactful for aging and postoperative recovery, though some remain cautious about broad applications.
Infusion of young donor plasma components in older patients modifies the immune and inflammatory response to surgical tissue injury: a randomized clinical trial "
February's Longevity Review is now out, looking how the combination of Omega 3, Vit D & exercise can slow aging; a human trial of young blood plasma; Klotho gene therapy to increase lifespan; and how cellular reprogramming protects retinal neurons. https://t.co/FXrHBFVT3v
Researchers from @Stanford have published the results of a randomized, controlled clinical trial demonstrating that young plasma decreases inflammation after surgery in trial. By Brice Gaudilliere, @amytsaii, @NimaAghaeepour, et al. https://t.co/ScHViobvzv https://t.co/g99U8Mntm6
Longevity Snapshot 6 - Young Plasma Human Trial https://t.co/fjfJnSpy6f via @YouTube
Longevity Snapshot 6 - Reviewing a trial where young blood plasma was used during joint replacement surgery in older adults, reducing inflammation & speeding up recovery. This is one of the 1st trials of young plasma after many positive results in mice. https://t.co/3aSBmwrRZu
Infusion of young donor plasma components in older patients modifies the immune and inflammatory response to surgical tissue injury: a randomized clinical trial | Journal of Translational Medicine | Full Text https://t.co/OfLCVkozmA
This review covers February's key longevity studies, including omega-3, vitamin D, exercise effects, young blood plasma trials, Klotho gene therapy, and cellular reprogramming in neurological protection.
This video explores why some individuals experience cognitive changes after surgery. Dr. Martin Angst studies biological factors influencing brain resilience by tracking cardiac surgery patients, revealing insights that…
Reviewing a trial where young blood plasma was used during joint replacement surgery in older adults reducing immune system related inflammation and speeding up recovery. This human trial explores how plasma infusion…
3/3 To give you an idea of what I post about, here is my latest monthly video - February's Longevity Review. youtu.be/yC0lEEcbanc
RT @ChrisPollyanna1: February's Longevity Review is now out, looking how the combination of Omega 3, Vit D & exercise can slow aging; a hum…
February's Longevity Review is now out, looking how the combination of Omega 3, Vit D & exercise can slow aging; a human trial of young blood plasma; Klotho gene therapy to increase lifespan; and how cellular reprogramming protects retinal neurons. https://t.co/FXrHBFVT3v
Longevity Snapshot 6 - Young Plasma Human Trial https://t.co/fjfJnSpy6f via @YouTube
Longevity Snapshot 6 - Reviewing a trial where young blood plasma was used during joint replacement surgery in older adults, reducing inflammation & speeding up recovery. This is one of the 1st trials of young plasma after many positive results in mice. https://t.co/3aSBmwrRZu
RT @agingdoc1: Infusion of young donor plasma components in older patients modifies the immune and inflammatory response to surgical tissue…
Infusion of young donor plasma components in older patients modifies the immune and inflammatory response to surgical tissue injury: a randomized clinical trial "
Infusion of young donor plasma components in older patients modifies the immune and inflammatory response to surgical tissue injury: a randomized clinical trial | Journal of Translational Medicine | Full Text https://t.co/OfLCVkozmA
Researchers from @Stanford have published the results of a randomized, controlled clinical trial demonstrating that young plasma decreases inflammation after surgery in trial. By Brice Gaudilliere, @amytsaii, @NimaAghaeepour, et al. https://t.co/ScHViobvzv https://t.co/g99U8Mntm6